AAAAAA

   
Results: 1-8 |
Results: 8
COST-EFFICIENT STENTING - A MULTIFACETED APPROACH
Authors: KEREIAKES DJ MCDONALD MB ABBOTTSMITH CW BRODERICK TM ROTH EM WHANG DD HATTEMER CR RUNYON JP SCHNEIDER JF
Citation: Dj. Kereiakes et al., COST-EFFICIENT STENTING - A MULTIFACETED APPROACH, Journal of the American College of Cardiology, 31(2), 1998, pp. 492-492
EFFICACY OF ABCIXIMAB INDUCED PLATELET BLOCKADE USING A RAPID POINT OF CARE ASSAY
Authors: KEREIAKES DJ ROTH EM HOWARD W ANDERSON LC IBANEZ KS HIGBY NA MUELLER MN LACOCK P ABBOTTSMITH CW
Citation: Dj. Kereiakes et al., EFFICACY OF ABCIXIMAB INDUCED PLATELET BLOCKADE USING A RAPID POINT OF CARE ASSAY, Circulation, 98(17), 1998, pp. 1305-1305
PHARMACODYNAMIC EFFICACY, CLINICAL SAFETY, AND OUTCOMES AFTER PROLONGED PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR BLOCKADE WITH ORAL XEMILOFIBAN - RESULTS OF A MULTICENTER, PLACEBO-CONTROLLED, RANDOMIZED TRIAL/
Authors: KEREIAKES DJ KLEIMAN NS FERGUSON JJ MASUD Z BRODERICK TM ABBOTTSMITH CW RUNYON JP ANDERSON LC ANDERS RJ DREILING RJ HANTSBARGER GL BRYZINSKI B TOPOL EJ
Citation: Dj. Kereiakes et al., PHARMACODYNAMIC EFFICACY, CLINICAL SAFETY, AND OUTCOMES AFTER PROLONGED PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR BLOCKADE WITH ORAL XEMILOFIBAN - RESULTS OF A MULTICENTER, PLACEBO-CONTROLLED, RANDOMIZED TRIAL/, Circulation, 98(13), 1998, pp. 1268-1278
SUSTAINED PLATELET GP IIB IIIA BLOCKADE WITH ORAL XEMILOFIBAN - FINALRESULTS OF THE ORBIT TRIAL/
Authors: KEREIAKES DJ FERGUSON JJ MASUD AZ KLEIMAN NS ABBOTTSMITH CW ANDERS RJ HANTSBARGER GL KOWALSKI KG DREILING RJ
Citation: Dj. Kereiakes et al., SUSTAINED PLATELET GP IIB IIIA BLOCKADE WITH ORAL XEMILOFIBAN - FINALRESULTS OF THE ORBIT TRIAL/, Circulation, 96(8), 1997, pp. 2158-2158
CLINICAL CHARACTERISTICS AND LONG-TERM OUTCOME OF PATIENTS IN WHOM CONGESTIVE-HEART-FAILURE DEVELOPS AFTER THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION - DEVELOPMENT OF A PREDICTIVE MODEL
Authors: OCONNOR CM HATHAWAY WR BATES ER LEIMBERGER JD SIGMON KN KEREIAKES DJ GEORGE BS SAMAHA JK ABBOTTSMITH CW CANDELA RJ TOPOL EJ CALIFF RM
Citation: Cm. Oconnor et al., CLINICAL CHARACTERISTICS AND LONG-TERM OUTCOME OF PATIENTS IN WHOM CONGESTIVE-HEART-FAILURE DEVELOPS AFTER THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION - DEVELOPMENT OF A PREDICTIVE MODEL, The American heart journal, 133(6), 1997, pp. 663-673
MYOCARDIAL BRIDGING MAY PREDISPOSE TO CORONARY PERFORATION DURING ROTATIONAL ATHERECTOMY
Authors: BRODERICK TM KEREIAKES DJ WHANG DD TOLTZIS RJ ABBOTTSMITH CW
Citation: Tm. Broderick et al., MYOCARDIAL BRIDGING MAY PREDISPOSE TO CORONARY PERFORATION DURING ROTATIONAL ATHERECTOMY, The Journal of invasive cardiology, 8(3), 1996, pp. 161-163
ABCIXIMAB-ASSOCIATED PROFOUND THROMBOCYTOPENIA - THERAPY WITH IMMUNOGLOBULIN AND PLATELET TRANSFUSION
Authors: KEREIAKES DJ ESSELL JH ABBOTTSMITH CW BRODERICK TM RUNYON JP
Citation: Dj. Kereiakes et al., ABCIXIMAB-ASSOCIATED PROFOUND THROMBOCYTOPENIA - THERAPY WITH IMMUNOGLOBULIN AND PLATELET TRANSFUSION, The American journal of cardiology, 78(10), 1996, pp. 1161
CLINICAL IMPORTANCE OF THROMBOCYTOPENIA OCCURRING IN THE HOSPITAL PHASE AFTER ADMINISTRATION OF THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION
Authors: HARRINGTON RA SANE DC CALIFF RM SIGMON KN ABBOTTSMITH CW CANDELA RJ LEE KL TOPOL EJ
Citation: Ra. Harrington et al., CLINICAL IMPORTANCE OF THROMBOCYTOPENIA OCCURRING IN THE HOSPITAL PHASE AFTER ADMINISTRATION OF THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION, Journal of the American College of Cardiology, 23(4), 1994, pp. 891-898
Risultati: 1-8 |